Covered recipient · General Payments record
MADHUSUDHAN R BANDA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2023
$6,209.10
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $870.00 | 1 |
| Food and Beverage | $505.45 | 13 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $1,064.09 | 5 |
| Amgen Inc. | $133.36 | 2 |
| Xeris Pharmaceuticals, Inc. | $49.61 | 1 |
| Abbott Laboratories | $40.34 | 2 |
| SANOFI-AVENTIS U.S. LLC | $28.27 | 1 |
| PFIZER INC. | $21.02 | 1 |
| DEXCOM, INC. | $20.02 | 1 |
| Lilly USA, LLC | $18.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.63 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018869089 | CMS |
| Abbott Laboratories | $18.71 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018899765 | CMS |
| Amgen Inc. | $124.24 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020006075 | CMS |
| Amgen Inc. | $9.12 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020006073 | CMS |
| Dexcom, Inc. | $20.02 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054667069 | CMS |
| Lilly USA, LLC | $18.74 | 04/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031784113 | CMS |
| Novo Nordisk Inc | $23.85 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001992381 | CMS |
| Novo Nordisk Inc | $21.84 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001992371 | CMS |
| Novo Nordisk Inc | $24.03 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001992391 | CMS |
| Novo Nordisk Inc | $124.37 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001992401 | CMS |
| Novo Nordisk Inc | $870.00 | 11/16/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1001992411 | CMS |
| PFIZER INC. | $21.02 | 08/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050554051 | CMS |
| SANOFI-AVENTIS U.S. LLC | $28.27 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049982613 | CMS |
| Xeris Pharmaceuticals, Inc. | $49.61 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056479279 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.